zirconium has been researched along with Multiple Myeloma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, MS; Piatkov, K; Wang, H; Yoneyama, T; Zhu, AZX | 1 |
1 other study(ies) available for zirconium and Multiple Myeloma
| Article | Year |
|---|---|
Leveraging a physiologically-based quantitative translational modeling platform for designing B cell maturation antigen-targeting bispecific T cell engagers for treatment of multiple myeloma.
Topics: Antibodies, Monoclonal; B-Cell Maturation Antigen; Humans; Multiple Myeloma; Radioisotopes; T-Lymphocytes; Tissue Distribution; Zirconium | 2022 |